ID: ALA4217249

Max Phase: Preclinical

Molecular Formula: C15H23NO3

Molecular Weight: 265.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(CCNC(=O)C(C)(C)C)cc1OC

Standard InChI:  InChI=1S/C15H23NO3/c1-15(2,3)14(17)16-9-8-11-6-7-12(18-4)13(10-11)19-5/h6-7,10H,8-9H2,1-5H3,(H,16,17)

Standard InChI Key:  VIFJQAYJHWCHNX-UHFFFAOYSA-N

Associated Targets(non-human)

Uterus (65 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 265.35Molecular Weight (Monoisotopic): 265.1678AlogP: 2.41#Rotatable Bonds: 5
Polar Surface Area: 47.56Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.69CX LogD: 2.69
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.89Np Likeness Score: -0.59

References

1. Domokos D, Fülöp F, Falkay G, Gáspár R..  (2018)  Effects of newly synthetized isoquinoline derivatives on rat uterine contractility and ROCK II activity.,  28  (3): [PMID:29269216] [10.1016/j.bmcl.2017.12.017]

Source